Monoclonal Antibody Therapeutics Market Report

Global and Region Monoclonal Antibody Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：221
  • REPORT CODE：GMM946119
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Monoclonal Antibody therapy refers to a form of immunotherapy that uses monoclonal antibodies (mAb) to bind mono specifically to certain cells or proteins. Monoclonal antibodies are being used to treat severe and chronic diseases such as rheumatoid arthritis, Crohn's disease, psoriasis, osteoporosis, systemic lupus erythematosus and certain types of cancer.

    Increasing focus on biomedical, stem cell and cancer research is a key factor contributing to the dominant market share in North America. The global Monoclonal Antibody Therapeutics market size is expected to gain growth in the forecast period of 2020 to 2026, with a CAGR of 6.9% and will expected to reach USD 146521 million by 2026.

    The increasing use of monoclonal antibody therapy in the treatment of cancer and autoimmune diseases is a factor that promotes the market development of Monoclonal Antibody Therapeutics. Besides, increased funding from government agencies for proteomics and genomics research is another factor expected to contribute to market growth during the forecast period. However, factors such as high costs and stringent government regulations will limit market growth over the forecast period.

    The report details the trend, potential and market size of Monoclonal Antibody Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Monoclonal Antibody Therapeuticsmarket, defines the market attractiveness level of Monoclonal Antibody Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Monoclonal Antibody Therapeutics industry, describes the types of Monoclonal Antibody Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Monoclonal Antibody Therapeutics market and the development prospects and opportunities of Monoclonal Antibody Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Monoclonal Antibody Therapeutics market in Chapter 13.

    By Player:

    • Pfizer

    • Roche

    • GlaxoSmithKline

    • Sanofi

    • AbbVie

    • Merck

    • Novartis

    • Bayer

    By Type:

    • Humanized Antibody

    • Human Mouse Chimeric Antibody

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Monoclonal Antibody Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Monoclonal Antibody Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Monoclonal Antibody Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Monoclonal Antibody Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Monoclonal Antibody Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Monoclonal Antibody Therapeutics Consumption (2017-2022)

    • 7.2 United States Monoclonal Antibody Therapeutics Consumption (2017-2022)

    • 7.3 Europe Monoclonal Antibody Therapeutics Consumption (2017-2022)

    • 7.4 China Monoclonal Antibody Therapeutics Consumption (2017-2022)

    • 7.5 Japan Monoclonal Antibody Therapeutics Consumption (2017-2022)

    • 7.6 India Monoclonal Antibody Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Monoclonal Antibody Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Monoclonal Antibody Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Monoclonal Antibody Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Monoclonal Antibody Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Monoclonal Antibody Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Monoclonal Antibody Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Monoclonal Antibody Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Monoclonal Antibody Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Monoclonal Antibody Therapeutics Consumption Forecast (2022-2028)

    9 Global Monoclonal Antibody Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Monoclonal Antibody Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Humanized Antibody Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Human Mouse Chimeric Antibody Consumption and Growth Rate (2017-2022)

    • 9.2 Global Monoclonal Antibody Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Monoclonal Antibody Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Monoclonal Antibody Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Humanized Antibody Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Human Mouse Chimeric Antibody Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Monoclonal Antibody Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Monoclonal Antibody Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Monoclonal Antibody Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Monoclonal Antibody Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Monoclonal Antibody Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Monoclonal Antibody Therapeutics Market Competitive Analysis

    • 14.1 Pfizer

      • 14.1.1 Pfizer Company Details

      • 14.1.2 Pfizer Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Monoclonal Antibody Therapeutics Product and Service

    • 14.2 Roche

      • 14.2.1 Roche Company Details

      • 14.2.2 Roche Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Roche Monoclonal Antibody Therapeutics Product and Service

    • 14.3 GlaxoSmithKline

      • 14.3.1 GlaxoSmithKline Company Details

      • 14.3.2 GlaxoSmithKline Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Product and Service

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Details

      • 14.4.2 Sanofi Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi Monoclonal Antibody Therapeutics Product and Service

    • 14.5 AbbVie

      • 14.5.1 AbbVie Company Details

      • 14.5.2 AbbVie Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 AbbVie Monoclonal Antibody Therapeutics Product and Service

    • 14.6 Merck

      • 14.6.1 Merck Company Details

      • 14.6.2 Merck Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Merck Monoclonal Antibody Therapeutics Product and Service

    • 14.7 Novartis

      • 14.7.1 Novartis Company Details

      • 14.7.2 Novartis Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novartis Monoclonal Antibody Therapeutics Product and Service

    • 14.8 Bayer

      • 14.8.1 Bayer Company Details

      • 14.8.2 Bayer Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bayer Monoclonal Antibody Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Monoclonal Antibody Therapeutics

    • Figure Monoclonal Antibody Therapeutics Picture

    • Table Global Monoclonal Antibody Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Monoclonal Antibody Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Monoclonal Antibody Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Monoclonal Antibody Therapeutics Consumption by Country (2017-2022)

    • Figure United States Monoclonal Antibody Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Monoclonal Antibody Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Monoclonal Antibody Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Monoclonal Antibody Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Monoclonal Antibody Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Monoclonal Antibody Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibody Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Monoclonal Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Monoclonal Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Monoclonal Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Monoclonal Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Monoclonal Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Monoclonal Antibody Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Humanized Antibody Consumption and Growth Rate (2017-2022)

    • Figure Global Human Mouse Chimeric Antibody Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Humanized Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human Mouse Chimeric Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Monoclonal Antibody Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Monoclonal Antibody Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Monoclonal Antibody Therapeutics Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Monoclonal Antibody Therapeutics Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Monoclonal Antibody Therapeutics Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Monoclonal Antibody Therapeutics Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Monoclonal Antibody Therapeutics Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Monoclonal Antibody Therapeutics Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Monoclonal Antibody Therapeutics Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Monoclonal Antibody Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Monoclonal Antibody Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US